Share

Marks, Pip au

List of all publications

Publishing since 2006 (Baby)

    2010

  1. Journal Article Studler U, White LM, Naraghi AM, Tomlinson G, Kunz M, Kahn G, Marks P. Anterior cruciate ligament reconstruction by using bioabsorbable femoral cross pins: MR imaging findings at follow-up and comparison with clinical findings.  Radiology  2010;255;1  Link to Anterior cruciate ligament reconstruction by using bioabsorbable femoral cross pins: MR imaging findings at follow-up and comparison with clinical findings.
  2. Journal ArticleResearch Support, N.I.H., Extramural Grebely J, Petoumenos K, Matthews GV, Haber P, Marks P, Lloyd AR, Kaldor JM, Dore GJ, Hellard M. Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.  Drug Alcohol Depend  2010;107;2-3  Link to Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
  3. Journal ArticleMulticenter StudyResearch Support, N.I.H., Extramural Dore GJ, Hellard M, Matthews GV, Grebely J, Haber PS, Petoumenos K, Yeung B, Marks P, van Beek I, McCaughan G, White P, French R, Rawlinson W, Lloyd AR, Kaldor JM. Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.  Gastroenterology  2010;138;1  Link to Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.

    4. 2009

  4. Clinical TrialJournal ArticleMulticenter StudyResearch Support, N.I.H., Extramural Matthews GV, Seaberg E, Dore GJ, Bowden S, Lewin SR, Sasadeusz J, Marks P, Goodman Z, Philp FH, Tang Y, Locarnini S, Thio CL. Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.  AIDS  2009;23;13  Link to Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.
  5. Journal ArticleResearch Support, N.I.H., Extramural Chang JJ, Sirivichayakul S, Avihingsanon A, Thompson AJ, Revill P, Iser D, Slavin J, Buranapraditkun S, Marks P, Matthews G, Cooper DA, Kent SJ, Cameron PU, Sasadeusz J, Desmond P, Locarnini S, Dore GJ, Ruxrungtham K, Lewin SR. Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.  J. Virol.  2009;83;15  Link to Impaired quality of the hepatitis B virus (HBV)-specific T-cell response in human immunodeficiency virus type 1-HBV coinfection.
  6. Comparative StudyJournal ArticleRandomized Controlled TrialResearch Support, N.I.H., Extramural Lewin SR, Ribeiro RM, Avihingsanon A, Bowden S, Matthews G, Marks P, Locarnini SA, Ruxrungtham K, Perelson AS, Dore GJ. Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.  Hepatology  2009;49;4  Link to Viral dynamics of hepatitis B virus DNA in human immunodeficiency virus-1-hepatitis B virus coinfected individuals: similar effectiveness of lamivudine, tenofovir, or combination therapy.
  7. Journal ArticleMulticenter StudyResearch Support, N.I.H., Extramural Matthews GV, Hellard M, Haber P, Yeung B, Marks P, Baker D, McCaughan G, Sasadeusz J, White P, Rawlinson W, Lloyd A, Kaldor J, Dore GJ. Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.  Clin. Infect. Dis.  2009;48;5  Link to Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.
  8. Journal ArticleResearch Support, N.I.H., Extramural Eid J, Fehr A, Gray J, Luong K, Lyle J, Otto G, Peluso P, Rank D, Baybayan P, Bettman B, Bibillo A, Bjornson K, Chaudhuri B, Christians F, Cicero R, Clark S, Dalal R, Dewinter A, Dixon J, Foquet M, Gaertner A, Hardenbol P, Heiner C, Hester K, Holden D, Kearns G, Kong X, Kuse R, Lacroix Y, Lin S, Lundquist P, Ma C, Marks P, Maxham M, Murphy D, Park I, Pham T, Phillips M, Roy J, Sebra R, Shen G, Sorenson J, Tomaney A, Travers K, Trulson M, Vieceli J, Wegener J, Wu D, Yang A, Zaccarin D, Zhao P, Zhong F, Korlach J, Turner S. Real-time DNA sequencing from single polymerase molecules.  Science  2009;323;5910  Link to Real-time DNA sequencing from single polymerase molecules.

    9. 2008

  9. Journal Article Saupe N, White LM, Chiavaras MM, Essue J, Weller I, Kunz M, Hurtig M, Marks P. Anterior cruciate ligament reconstruction grafts: MR imaging features at long-term follow-up--correlation with functional and clinical evaluation.  Radiology  2008;249;2  Link to Anterior cruciate ligament reconstruction grafts: MR imaging features at long-term follow-up--correlation with functional and clinical evaluation.
  10. Journal ArticleRandomized Controlled Trial Matthews GV, Avihingsanon A, Lewin SR, Amin J, Rerknimitr R, Petcharapirat P, Marks P, Sasadeusz J, Cooper DA, Bowden S, Locarnini S, Ruxrungtham K, Dore GJ. A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.  Hepatology  2008;48;4  Link to A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.

    11. 2007

  11. Journal Article Marks P, Williams R. Alcohol-related road traffic accidents: promoting a lower alcohol strategy.  Clin Med  2007;7;4  Link to Alcohol-related road traffic accidents: promoting a lower alcohol strategy.
  12. Journal Article Hricak V, Liska B, Kovackova J, Mikusova J, Fischer V, Kovacik J, Karvaj M, Jurco R, Ondrusova A, Kalavsky E, Marks P, Beno P, Krcmery V. Trends in risk factors and etiology of 606 cases of infective endocarditis over 23 years (1984-2006) in slovakia.  J Chemother  2007;19;2  Link to Trends in risk factors and etiology of 606 cases of infective endocarditis over 23 years (1984-2006) in slovakia.

    13. 2006

  13. Clinical Trial, Phase IIIJournal ArticleMulticenter StudyRandomized Controlled Trial Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D. A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.  Blood  2006;107;9  Link to A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia.
  14. Journal Article Gregg JM, Silberstein M, Schneider T, Kerr JB, Marks P. Sonography of plantar plates in cadavers: correlation with MRI and histology.  AJR Am J Roentgenol  2006;186;4  Link to Sonography of plantar plates in cadavers: correlation with MRI and histology.
  15. Journal ArticleResearch Support, N.I.H., Extramural O'Connor OA, Heaney ML, Schwartz L, Richardson S, Willim R, MacGregor-Cortelli B, Curly T, Moskowitz C, Portlock C, Horwitz S, Zelenetz AD, Frankel S, Richon V, Marks P, Kelly WK. Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.  J. Clin. Oncol.  2006;24;1  Link to Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies.
Back to page of Marks, Pip.

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.